Pilot Access to AI-Enabled Evidence Workflows
Early Access for Members
Following the strong interest generated by our presentation at ISPOR 2026, we are opening complimentary access to a limited pilot of ECNE Research's AI-enabled, expert-supervised evidence workflows. Available to a select number of organisations on a first come, first served basis, the pilot is designed for teams working across HEOR, Medical Affairs, Regulatory Affairs, Market Access, Literature Reviews, Medical Writing, and Clinical Evidence Strategy.
Participants will explore how expert-supervised AI workflows can support faster evidence reviews, systematic literature review activities, continuous literature surveillance, regulatory and medical intelligence monitoring, and structured evidence package development.
By combining AI efficiency with expert oversight, our approach helps organisations accelerate evidence generation while maintaining transparency, methodological rigour, and defensible outputs. A limited number of complimentary pilot places are now available.
White Paper
The Vital Role of Literature Reviews in Pharmacovigilance
In the ever-changing pharmaceutical industry, safeguarding the safety and efficacy of medicinal products has become more crucial than ever. With regulatory standards growing increasingly rigorous, patient safety remains a top priority.
Read more in our latest whitepaper.
Be the first to know
Sign up to our mailing list to receive regular updates on medical writing and clinical research topics.